General Information
DRAVP ID DRAVPe00431
Peptide Name EKL1
Sequence NVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEY
Sequence Length 36
UniProt ID No entry found
Source Synthetic construct(derived from EK1)
Activity Information
Target Organism SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63
Assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity No cytotoxicity information found in the reference(s) presented
Binding Target membrane
Mechanism The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells.
Structure Information
PDB ID None
Predicted Structure Download DRAVPe00431
Linear/Cyclic Linear
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C201H312N42O65S
Absent amino acids CHPQRW
Common amino acids E
Mass 4388.99
Pl 4.39
Basic residues 5
Acidic residues 10
Hydrophobic residues 11
Net charge -5
Boman Index -6393
Hydrophobicity -64.72
Aliphatic Index 97.5
Half Life
Extinction Coefficient cystines 5960
Absorbance 280nm 170.29
Polar residues 9
Literature Information
Literature 1
Title A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.
Pubmed ID 34367893
Reference Acta Pharm Sin B. 2021 Aug 2.
Author Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q.